Page last updated: 2024-08-24

lamivudine and Astrocytoma, Grade IV

lamivudine has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chheda, MG; Doherty, LM; Drappatz, J; Gigas, DC; Greenberger, NJ; Kesari, S; Weiss, SE; Wen, PY	1

Other Studies

1 other study(ies) available for lamivudine and Astrocytoma, Grade IV

Article	Year
Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note. Neurology, 2007, Mar-20, Volume: 68, Issue:12 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; DNA, Viral; Glioblastoma; Hepatitis B; Humans; Immunocompromised Host; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Patient Selection; Reverse Transcriptase Inhibitors; Risk Factors; Spinal Neoplasms; Temozolomide; Treatment Outcome; Viral Load; Virus Activation	2007

Article

Year

Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.

Neurology, 2007, Mar-20, Volume: 68, Issue:12

Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; DNA, Viral; Glioblastoma; Hepatitis B; Humans; Immunocompromised Host; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Patient Selection; Reverse Transcriptase Inhibitors; Risk Factors; Spinal Neoplasms; Temozolomide; Treatment Outcome; Viral Load; Virus Activation

2007